Top Markets
#1 Tensor Tensor +38.76%
#2 Ontology Gas Ontology Gas +19.99%
#3 Blur Blur +19.25%
#4 XPIN Network XPIN Network +12.27%
#5 Naoris Protocol Naoris Protocol +12.17%
#6 Corn Corn +10.72%
#7 Irys Irys +10.19%
#8 Magma Finance Magma Finance +9.13%
#9 Enjin Coin Enjin Coin +8.97%
#10 Supra Supra +8.92%
Coin of the day
Tensor Tensor
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Clinical Laserthermia Systems AB (publ) Clinical Laserthermia Systems AB (publ)

Clinical Laserthermia Systems AB (publ)

CLS-B
Rang in aandelen #16822
Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased... Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment. In addition, the company offers various gauge laser applicators, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
Aandeelprijs
$0.51099792
Marktkapitalisatie
$13.22M
Verandering (1 dag)
-0.54%
Verandering (1 jaar)
99.27%
Land
SE
Handel Clinical Laserthermia Systems AB (publ) (CLS-B)

Categorie

Healthcare
P/B-ratio voor Clinical Laserthermia Systems AB (publ) (CLS-B)
P/B-ratio op April 2026 TTM: 1.99
Volgens de meest recente financiële rapporten en aandelenkoers van Clinical Laserthermia Systems AB (publ) is de huidige P/B-ratio (TTM) 1.99. Eind 2023 had het bedrijf een P/B-ratio van 2.03.
P/B-ratiohistoriek voor Clinical Laserthermia Systems AB (publ) van 2008 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
2026 (TTM) 1.99 237.56%
2024 0.59 -71.05%
2023 2.03 -73.67%
2022 7.69 -28.81%
2021 10.81 -26.23%
2020 14.65 -50.47%
2019 29.58 587.26%
2018 4.30 -67.02%
2017 13.05 -1.35%
2016 13.23 45.08%
2015 9.12 115.27%
2014 4.24 -59.57%
2013 10.48 -99.58%
2012 2.49K -55.39%
2011 5.57K -3.48%
2010 5.77K 38.40%
2009 4.17K 8,518.09%
2008 48.40 0.00%
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 3.438 72.63%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 5.606 181.48%
US
Medtronic plc Medtronic plc
Medtronic plc
2M6.DE
 2.2679 13.87%
IE
Medtronic Medtronic
Medtronic
MDT.US
 2.2679 13.87%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 3.8394 92.78%
US